脂蛋白降低疗法:一个有希望的未来
Jingwen Zhang1, Ann Marie Navar2, Lale Tokgozoglu3
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
European heart journal
|February 13, 2026
概括
脂蛋白 (Lp) 显著增加了动脉样硬化心血管疾病的风险. 新兴疗法在降低Lp (a) 和降低心血管风险方面表现有前途,目前正在进行III期试验.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脂蛋白 (Lp) 是动脉样硬化心血管疾病 (ASCVD) 的主要遗传决定风险因素.
- 升高的Lp (a) 显著导致其余心血管风险,影响大量人群.
- 目前的治疗方法和生活方式的改变对Lp (a) 水平的影响很小;脂蛋白疏松是有效的,但不切实际的.
研究的目的:
- 审查当前治疗方法在Lp (a) 水平上的有限疗效.
- 为正在开发中的新型Lp (a) 向疗法提供最新信息.
- 讨论正在进行的第三阶段试验和Lp减少的潜在好处.
主要方法:
- 关于降脂疗法和Lp (a) 的现有文献的审查.
- 分析新兴的针对Lp (a) 的治疗方法,包括基于核酸的方法和小分子抑制剂.
- 检查二期试验和正在进行的三期结论试验的数据.
主要成果:
- 新兴的Lp(a) 向疗法,包括反感性寡核酸,小干扰RNA和小分子抑制剂,在第二阶段试验中显示出显著的Lp(a) 减少.
- 这些新型疗法显示出潜在的实质性和持久的Lp (a) 降低作用.
- 目前正在进行第三阶段试验,评估这些药物对ASCVD结局的影响.
结论:
- 新型Lp (a) 降低疗法在控制心血管风险方面是一个有希望的进步.
- 第三阶段试验的成功结果可能会改变ASCVD风险降低策略,用于患有升高Lp的患者.
- 潜在的益处可能延伸到减缓状大动脉狭窄症的进展.
相关概念视频
Vapor Pressure Lowering
31.5K
The equilibrium vapor pressure of a liquid is the pressure exerted by its gaseous phase when vaporization and condensation are occurring at equal rates:
31.5K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy
469
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
469
Behavior Therapy
745
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
745
Drug Therapy
308
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
308


